Notes on Acetylcholine Receptors

The diagram presents important amino acid residues for acetylcholine (ACh) receptors, including various alpha (α) and beta (β) subunits on the receptor.

ACh as a CNS Transmitter: Crucial for neurotransmission in the central nervous system.
CNS Nicotinic Receptors: Key in fast synaptic transmission.
CNS Muscarinic Receptors: Involved in long-term modulation and slower responses.
Functions of AChRs: Essential for processes like memory and motor control.
Drugs acting on CNS ACh receptors: Include both agonists and antagonists.
Diseases: Malfunctions can lead to disorders such as Alzheimer’s and Parkinson’s.

ACh Synthesis: Choline + Acetyl-CoA (AcCoA) via Choline Acetyltransferase (CAT).
Storage and Release: ACh is stored in vesicles, released by exocytosis, and degraded by Acetylcholinesterase (AChE).

Key Pathways: ACh pathways include interneurons in the retina, forebrain nuclei (septum), striatum, and various cortical areas.
Distribution: Found in GABAergic neurons in the striatum, linking ACh activities in different brain regions.

Fast Depolarization: Rapid change in membrane potential (e.g., 0mV to -70mV).
Slow Depolarization: Gradual increase from resting potential (-70mV).
Slow Hyperpolarization: Change from -70mV to -80mV, affecting excitability.

Structure: Comprised of 5 subunits. Include combinations like 2 × α1 + β1 for muscle and 2 × α + 3 × β in the CNS.
Subtypes: Includes α2 to α10, with specific combinations impacting receptor functionality.

Complexes: Displays the interaction between Alpha 4 and Beta 2 subunits in nAChR, highlighting genetic and structural impact on function.

Common Combinations: 2 × α4 + 3 × β2, and 5 × α7.
Variability: Different subunit combinations affect pharmacology, ion permeability, desensitization rates, and CNS localization.

Receptors Profiling: Examines potency (ACh EC50) and desensitization in structures like thalamus and hippocampus, revealing functional differences.

Important proteins for ACh: Synthesis, storage, degradation, and reuptake.
Three important brain nuclei with ACh neurons: Basal forebrain, septum, and striatum.
Electrical responses mediated by ACh: Fast depolarization and hyperpolarization.
Variability among nAChRs subtypes.

G-Protein Coupled Receptors: Includes M1 (cortex, hippocampus), M2 (basal forebrain, thalamus), M3 (widely distributed), M4, and M5 (substantia nigra).

Mechanism: Shows involvement of phospholipase C (PLC) and calcium-dependent pathways for muscarinic receptor activation and signaling.

Functionality: α3 (lethal), α4 (reduced analgesia), α7 (minimal changes), β2 (learning alterations), β3 (locomotion effects).
mAChR Effects: Involvement in memory, temperature control, and locomotor behavior alterations.

Agonists: Epibatidine (analgesic trial) and nicotine (dependency).
Partial Agonists: Varenicline for smoking cessation.
AChesterase Inhibitors: Used for Alzheimer's—donepezil, galantamine, rivastigmine.

Addiction: Increases dopamine in mesocorticolimbic pathways, enhancing reward mechanics similar to cocaine.
Physiological Impact: Smokers show nAChR upregulation; decreased incidence of neurodegenerative diseases.

Antagonists: Includes benztropine, biperiden, and others for motion sickness and early Parkinson's treatment.

Channelopathy: Related to mutations in CHRNA4, leading to symptoms during light sleep.
Genetic Linkage: Associated with specific chromosome loci and point mutations affecting receptor subunits.

Desensitization Impacts: Desensitization leads to slower recovery and altered calcium permeability at excitable receptors, contributing to hyperexcitability.

ACh Receptor Types: Ligand-gated (nicotinic) vs. G-protein coupled (muscarinic).
Functions: Involvement in learning, memory, motor control, and regulatory roles.
Therapeutic Targets: Many CNS conditions linked to ACh dysfunction have corresponding drug treatments.

List of significant literature references related to nAChRs and mAChRs providing foundational knowledge for further study and understanding of receptors in the CNS.